Skip to main content

Table 2 Treatments for chronic cystoid macular edema (cCME) and anatomical responses on spectral-domain optical coherence tomography

From: Macular edema after rhegmatogenous retinal detachment repair: risk factors, OCT analysis, and treatment responses

Type of treatment Anti-VEGF TA DEX  
Number of eyes 5 7 4  
Number of Injections (Median; [Range]) 2.5, 1-14 2.0, 1-10 2.5, 1-7  
CST pre-injection (μm) 401 ± 84.9 481 ± 104 397 ± 57.0 P = 0.397
CST post-injection (μm) 393 ± 106 402 ± 102 355 ± 80.4  
Percent CST change (μm) − 1.44 ± 17.1, P = 0.915 − 15.6 ± 16.6, P = 0.016 − 11.0 ± 10.7, P = 0.434  
Inner macular volume pre-injection (mm3) 2.81 ± 0.43 3.18 ± 0.56 3.12 ± 0.80 P = 0.457
Inner macular volume post-injection (mm3) 2.74 ± 0.53 2.72 ± 0.53 2.66 ± 0.486  
Percent (%) inner macular volume change (mm3) −2.49 ± 12.35, P = 0.828 −13.9 ± 10.8, P = 0.016 −10.7 ± 25.7, P = 0.125  
  1. Values are listed as averages with standard deviations
  2. VEGF vascular endothelial growth factor, TA triamcinolone acetate, DEX dexamethasone implant, CST central subfield thickness